Human innate-defense peptide; beta-defensin
Beta-defensin 3
Human beta-defensin 3 was isolated from cutaneous material and molecularly characterized. Antimicrobial activity, chemotactic activity and disulfide organization address different properties and are not interchangeable measures of quality.
This is a research reference, not a product offered in the Asciende catalog. Published studies do not establish the identity, purity or availability of a commercial preparation.
Activity in a model and assay conditions
Separate result and explanation. Activity under particular conditions does not define a specification for every material using the same name.
- Does the observation come from a cellular system, microorganism or whole organism?
- Are vehicle, medium and controls that may change the readout reported?
- Does the observed marker demonstrate the proposed mechanism or merely remain compatible with it?
Mechanism described in the literature
In vitro variants with different disulfide connections retained activity against Escherichia coli but differed in chemotactic behavior. This does not make the different structures functionally equivalent in every assay.
Other names in the literature
- hBD-3
- HBD-3
- Human beta-defensin 3
Isolation and comparison of preparations
The original work isolated the peptide from human psoriatic scales and examined its expression in cells. Natural, recombinant and synthetic preparations were compared, but that comparison is not a certificate for any later material carrying the same name (PMID 11085990).
What ultrastructure can establish
Changes in Staphylococcus aureus ultrastructure were compatible with envelope perforation. Such observations do not establish every molecular step or demonstrate that the same sequence of events occurs in every species.
One functional assay cannot establish disulfide connectivity
Experiments with defined disulfide variants found similar activity against E. coli alongside differences in chemotaxis. An antimicrobial assay therefore cannot independently confirm the peptide's disulfide arrangement (PMID 12840147).
Questions and answers
Does similar antimicrobial activity confirm the same folding?
No. In the cited work, different disulfide arrangements could retain an antibacterial readout while differing in chemotaxis.
Are disulfide-free variants equivalent to the natural peptide?
That cannot be assumed. They are modified experimental materials whose identity and results must remain tied to the particular assay.
Sources
- Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. — J Biol Chem, 2001
- Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.
- Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. — Proc Natl Acad Sci U S A, 2003
- Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3.